Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bhagwan Yadav

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Computational and Structural Biotechnology Journal|July 12, 2018
Corrigendum to "Searching for drug synergy in complex dose-response landscapes using an interaction potency model" [Comput. Struct. Biotechnol. J. 13 (2015) 504-513]Bhagwan Yadav, Krister Wennerberg, Tero Aittokallio, et al.
Computational and Structural Biotechnology Journal|March 8, 2016
Searching for Drug Synergy in Complex Dose-Response Landscapes Using an Interaction Potency ModelBhagwan Yadav, Krister Wennerberg, Tero Aittokallio, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 7, 2018
Integrated Analysis of Drug Sensitivity and Selectivity to Predict Synergistic Drug Combinations and Target Coaddictions in CancerAlok Jaiswal, Bhagwan Yadav, Krister Wennerberg, et al.
Plos Computational Biology|September 27, 2013
Target inhibition networks: predicting selective combinations of druggable targets to block cancer survival pathwaysJing Tang, Leena Karhinen, Tao Xu, et al.
Molecular Cancer|May 12, 2016
Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cellsPrson Gautam, Leena Karhinen, Agnieszka Szwajda, et al.
Disease Models & Mechanisms|October 7, 2015
From drug response profiling to target addiction scoring in cancer cell modelsBhagwan Yadav, Peddinti Gopalacharyulu, Tea Pemovska, et al.
AIDS (London, England)|January 28, 2025
Adipose tissue transcriptome in patients switching efavirenz or a protease inhibitor to raltegravir compared to people without HIVAnna M Hanttu, Maheswary Muniandy, Birgitta W van der Kolk, et al.
Chemistry & Biology|July 28, 2015
Systematic Mapping of Kinase Addiction Combinations in Breast Cancer Cells by Integrating Drug Sensitivity and Selectivity ProfilesAgnieszka Szwajda, Prson Gautam, Leena Karhinen, et al.
Nature|December 2, 2016
Consistency in drug response profilingJohn Patrick Mpindi, Bhagwan Yadav, Päivi Östling, et al.
Bioinformatics (Oxford, England)|March 3, 2020
Breeze: an integrated quality control and data analysis application for high-throughput drug screeningSwapnil Potdar, Aleksandr Ianevski, John-Patrick Mpindi, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Computational and Structural Biotechnology Journal|July 12, 2018
Corrigendum to "Searching for drug synergy in complex dose-response landscapes using an interaction potency model" [Comput. Struct. Biotechnol. J. 13 (2015) 504-513]Bhagwan Yadav, Krister Wennerberg, Tero Aittokallio, et al.
Computational and Structural Biotechnology Journal|March 8, 2016
Searching for Drug Synergy in Complex Dose-Response Landscapes Using an Interaction Potency ModelBhagwan Yadav, Krister Wennerberg, Tero Aittokallio, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 7, 2018
Integrated Analysis of Drug Sensitivity and Selectivity to Predict Synergistic Drug Combinations and Target Coaddictions in CancerAlok Jaiswal, Bhagwan Yadav, Krister Wennerberg, et al.
Plos Computational Biology|September 27, 2013
Target inhibition networks: predicting selective combinations of druggable targets to block cancer survival pathwaysJing Tang, Leena Karhinen, Tao Xu, et al.
Molecular Cancer|May 12, 2016
Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cellsPrson Gautam, Leena Karhinen, Agnieszka Szwajda, et al.
Disease Models & Mechanisms|October 7, 2015
From drug response profiling to target addiction scoring in cancer cell modelsBhagwan Yadav, Peddinti Gopalacharyulu, Tea Pemovska, et al.
AIDS (London, England)|January 28, 2025
Adipose tissue transcriptome in patients switching efavirenz or a protease inhibitor to raltegravir compared to people without HIVAnna M Hanttu, Maheswary Muniandy, Birgitta W van der Kolk, et al.
Chemistry & Biology|July 28, 2015
Systematic Mapping of Kinase Addiction Combinations in Breast Cancer Cells by Integrating Drug Sensitivity and Selectivity ProfilesAgnieszka Szwajda, Prson Gautam, Leena Karhinen, et al.
Nature|December 2, 2016
Consistency in drug response profilingJohn Patrick Mpindi, Bhagwan Yadav, Päivi Östling, et al.
Bioinformatics (Oxford, England)|March 3, 2020
Breeze: an integrated quality control and data analysis application for high-throughput drug screeningSwapnil Potdar, Aleksandr Ianevski, John-Patrick Mpindi, et al.
Pageof 4